Page 37 - Daniel Bush News Today : Breaking News, Live Updates & Top Stories | Vimarsana

FDA Grants Priority Review for New Drug Application for Oleogel-S10 for the Treatment of Epidermolysis Bullosa PDUFA date of DUBLIN, Ireland, and Boston MA, June 3, 2021, Amryt (Nasdaq: AMYT, AIM: AMYT), a global, commercial-stage biopharmaceutical company dedicated to acquiring, developing and commercializing novel treatments for rare diseases, today announces that the U.S. Food and Drug Administration (“FDA”) has granted Priority Review for Amryt’s New Drug Application (“NDA”) for Oleogel-S10 for the treatment of Epidermolysis Bullosa (“EB”).  Oleogel-S10 is a potent...

*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient: 1. Obtains access to the information in a personal capacity; 2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services; 3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional bod...

Investegate announcements from Touchstone Explrtn., EXERCISE OF SHARE OPTIONS

  OnTheMarket plc, the majority agent-owned company which operates the OnTheMarket.com   property portal, is pleased to announce, further to the announcement of 22 March 2021, that it has now completed the acquisition of Glanty Ltd ("Glanty").   The initial consideration of £1,533,477 (the "Initial Consideration") required to be paid by OnTheMarket under the share purchase agreement is being satisfied by way of the issue of 1,528,832 ordinary shares of 0.2 pence each in the capital of OnTheMarket in aggregate (the "Consideration Shares") and ...

Investegate announcements from Nucleus Financial Gp, Result of AGM